InspireMD Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
InspireMD, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue7.016.215.174.502.493.723.60
Cost of Revenue5.504.404.053.742.402.972.61
Gross Profit1.511.811.120.750.080.761.00
Operating Expenses
Research & Development13.637.987.815.162.232.951.54
Selling, General & Administrative21.3814.9712.0210.318.237.627.07
Operating Expenses35.0122.9519.8315.4710.4610.578.61
Operating Income-33.50-21.14-18.71-14.72-10.38-9.82-7.61
Other Income/Expense
Interest Income1.561.290.250.000.000.000.00
Interest Expense0.000.000.00-0.16-0.160.000.00
Other Income/Expense1.56-1.29-0.250.160.160.200.00
Income
Income Before Tax-31.95-19.85-18.46-14.87-10.54-10.02-7.24
Income Tax Expense0.060.070.030.050.000.020.00
Net Income-32.01-19.92-18.49-14.92-10.54-10.04-7.24
Net Income - Continuous Operations-32.01-19.92-18.49-14.920.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA-33.22-20.91-18.53-14.56-10.23-10.17-7.46
EBIT-33.50-21.14-18.71-14.72-10.38-10.02-7.61
Depreciation & Amortization0.280.230.190.160.150.000.00
Earnings Per Share
Basic EPS-1.00-1.00-2.00-2.00--5.00-250.00
Diluted EPS-1.00-1.00-2.00-2.00--5.00-250.00
Basic Shares Outstanding41.9324.277.877.3522.692.090.03
Diluted Shares Outstanding41.9324.277.877.3522.692.090.03